Animal Models & Clinical Trials

The development of human vaccines continues to rely on the use of animals for research. Regulatory authorities require novel vaccine candidates to undergo preclinical assessment in animal models before being permitted to enter the clinical phase in human subjects. Substantial progress has been made in recent years in reducing and replacing the number of animals used for preclinical vaccine research through the use of bioinformatics and computational biology to design new vaccine candidates. However, the ultimate goal of a new vaccine is to instruct the immune system to elicit an effective immune response against the pathogen of interest, and no alternatives to live animal use currently exist for evaluation of this response.

 


    Related Conference of Animal Models & Clinical Trials

    June 23-24, 2021

    34th World Congress on Vaccines and Immunization

    Osaka, Australia
    June 24-25, 2021

    9th World Summit on immunology & immunotherapy

    Prague, Czech Republic
    June 29-29, 2021

    3rd International Conference on Dermatology and Allergic Diseases

    Singapore City, Singapore
    July 08-09, 2021

    International Online Conference on Immunology

    New York, USA
    August 27-28, 2021

    5th International Conference on Emerging Infectious Diseases

    Amsterdam, Netherlands
    October 12-13, 2021

    International Conference on Vaccine and Vaccine research

    Manila, Philippines
    October 14-15, 2021

    13th Annual Conference on Clinical Immunology

    Cape Town, South Africa
    October 14-15, 2021

    11th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa
    November 10-11, 2021

    International Conference on Immunology Research

    New York, USA

    Animal Models & Clinical Trials Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in